Related references
Note: Only part of the references are listed.Beta-Blocker-Induced Heart Rate Reduction Too Simplistic to Explain the Deleterious Effects of Beta-Blockers
Stephane Laurent et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Increased Aortic Pulse Wave Velocity Is Associated With Silent Cerebral Small-Vessel Disease in Hypertensive Patients
Leon H. G. Henskens et al.
HYPERTENSION (2008)
A comparison of atenolol and nebivolol in isolated systolic hypertension
Zahid Dhakam et al.
JOURNAL OF HYPERTENSION (2008)
Relation of Beta-Blocker-Induced Heart Rate Lowering and Cardioprotection in Hypertension
Sripal Bangalore et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effects of extended-release metoprolol succinate inpatients undergoing non-cardiac surgery (POISE trial):: a randomised controlled trial
P. J. Devereaux et al.
LANCET (2008)
Treatment of hypertension in patients 80 years of age or older
Nigel S. Beckett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Long-term follow-up after tight control of blood pressure in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
UKPDS and the legacy effect
John Chalmers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of a multifactorial intervention on mortality in type 2 diabetes
Peter Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger people: meta-analysis of randomised trials
F. Turnbull et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Increased wall: Lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event
Joanna M. Harazny et al.
HYPERTENSION (2007)
Aortic distensibility and retinal arteriolar narrowing - The multi-ethnic study of atherosclerosis
Ning Cheung et al.
HYPERTENSION (2007)
Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension
Pierre Fesler et al.
JOURNAL OF HYPERTENSION (2007)
Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: The Hoorn study
Marc M. H. Hermans et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension
Ben Ariff et al.
STROKE (2006)
Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients
Carmine Savoia et al.
HYPERTENSION (2006)
Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives
Anne-Isabelle Tropeano et al.
HYPERTENSION (2006)
Should β blockers remain first choice in the treatment of primary hypertension?: A meta-analysis
LH Lindholm et al.
LANCET (2005)
Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss
O Hanon et al.
STROKE (2005)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Relationship between aortic stiffening and microvascular disease in brain and kidney - Cause and logic of therapy
MF O'Rourke et al.
HYPERTENSION (2005)
Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension
JC Verhave et al.
HYPERTENSION (2005)
Arterial pressure lowering effect of chronic atenolol therapy in hypertension and vasoconstrictor sympathetic drive
J Burns et al.
HYPERTENSION (2004)
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy -: A Losartan Intervention For Endpoint Reduction (LIFE) substudy
SE Kjeldsen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
LH Lindholm et al.
LANCET (2002)
Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension
JB Park et al.
JOURNAL OF HYPERTENSION (2001)
Share Paper
